Delivery Order SPE2DE24D0013-SPE2D626F8704
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a $10.2K firm fixed-price delivery order to Cepheid Inc. on October 31, 2025, for the XpertXpress COVID-19, Influenza, and RSV molecular diagnostic kit. The contract, which carries no set-aside designation, is scheduled for completion by November 7, 2025, with performance to take place at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of the federal government's reliance on Cepheid's rapid...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a $14,037.50 firm fixed-price delivery order on November 3, 2025, for the Kit Xpert Xpress COVID-19, Flu, RSV + Molecular Biology diagnostic testing supplies. The contract, which is not subject to any set-aside designation, has an ultimate completion date of November 10, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of DLA Medical Supply Chain's...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded Cepheid Inc. a delivery order valued at $22,240 on September 9, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit...
- The Defense Logistics Agency issued a $34,223.80 firm fixed-price delivery order to Cepheid Inc. on September 15, 2025, for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing supplies and services. The contract, designated as XPCOV2/FLU/RSV-10, carries an ultimate completion date of September 22, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order does not utilize a set-aside designation and represents a continuation of...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a firm fixed-price delivery order valued at $8,160 on October 28, 2025, for diagnostic reagents and test kits related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, designated XPCOV2/FLU/RSV-10, carries an ultimate completion date of November 4, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. This award utilizes no set-aside designation,...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. for the supply of XPert Xpress COVID-19, Influenza, and RSV molecular diagnostic test kits. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 10, 2025, represents a routine procurement under Cepheid's existing federal contract vehicles. The work will be performed at Cepheid's facility in Sunnyvale,...
- The U.S. Defense Medical Supply Chain has awarded a $10,380 firm fixed-price delivery order to Cepheid Inc. for COVID-19/Influenza/Respiratory Syncytial Virus (RSV) diagnostic testing solutions. The contract, designated as delivery order 4568136312, was awarded on May 2, 2025, with an ultimate completion date of May 9, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of the federal...
- The Defense Logistics Agency's Medical Supply Chain has awarded a $7,904 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, represents procurement of diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract was awarded on September 8, 2025, with an ultimate completion date of September 15, 2025, and carries no...
- The Defense Logistics Agency Medical Supply Chain awarded a $6,732.00 firm fixed-price delivery order to Cepheid Inc. on October 27, 2025, for SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) diagnostic testing supplies. The contract, which carries no set-aside designation, is scheduled for completion by November 10, 2025, with performance to be executed at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a routine procurement of molecular diagnostic...
- The Defense Logistics Agency's Medical Supply Chain awarded a $30,678.60 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) testing solutions. The contract, which carries no set-aside designation, was executed on August 19, 2025, with an ultimate completion date of August 26, 2025. This delivery order is likely issued under one of Cepheid's existing Indefinite...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F8704Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $10,550 firm fixed-price delivery order to Cepheid Inc. on November 3, 2025, for the Kit Xpert Xpress COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) plus Molecular Biology diagnostic testing supplies. The delivery order, which will be completed by November 10, 2025, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic solutions. This contract is not subject to any small business set-aside designation. The place of performance is located in Sunnyvale, California, where Cepheid maintains its headquarters and manufacturing operations for advanced diagnostic systems and reagents. Cepheid has established itself as a cornerstone supplier to multiple federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard, through its GeneXpert diagnostic platform and associated testing capabilities. The company holds substantial indefinite delivery contracts with the VA, including a $32.8 million agreement with VISN 6 extending through September 2030, demonstrating sustained federal reliance on its molecular diagnostic expertise. This delivery order for respiratory pathogen testing kits aligns with Cepheid's core competency in providing rapid molecular diagnostics for infectious disease detection and supports the Defense Logistics Agency's medical supply chain operations for federal healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 11/3/25 |